P504S/α-methylacyl-CoA racemase: A useful marker for diagnosis of small foci of prostatic carcinoma on needle biopsy

American Journal of Surgical Pathology

Volumn 26, Issue 9, 2002, Pages 1169-1174

  Jiang, Zhong ^a   Wu, Chin Lee ^b   Woda, Bruce A ^a   Dresser, Karen ^a   Xu, Jiangchun ^c   Fanger, Gary R ^c   Yang, Ximing J ^d  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c GLAXOSMITHKLINE   (United States)

^d UNIVERSITY OF CHICAGO   (United States)

Author keywords

Methylacyl CoA racemase; Limited prostate carcinoma; P504S

Indexed keywords

2 METHYLACYL COENZYME A RACEMASE; ACYL COENZYME A; COMPLEMENTARY DNA; RACEMASE; TUMOR MARKER; UNCLASSIFIED DRUG;

ARTICLE; BASAL CELL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC APPROACH ROUTE; DIAGNOSTIC VALUE; DISEASE MARKER; DNA MICROARRAY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; MALE; MOLECULAR WEIGHT; NEEDLE BIOPSY; PROSTATE ADENOCARCINOMA; PROSTATE CARCINOMA; PROTEIN EXPRESSION; RELIABILITY; SENSITIVITY AND SPECIFICITY;

ADENOCARCINOMA; BIOPSY, NEEDLE; HUMANS; IMMUNOENZYME TECHNIQUES; KERATINS; MALE; MOLECULAR WEIGHT; PROSTATIC NEOPLASMS; RACEMASES AND EPIMERASES; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL;

EID: 0036724798     PISSN: 01475185     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000478-200209000-00007     Document Type: Article

References (18)

1. Keratin immunoreactivity in the benign and neoplastic human prostate
2. The volume of prostate cancer in the biopsy specimen cannot reliably predict the quantity of cancer in the radical prostatectomy specimen on an individual basis
3. Increasing incidence of minimal residual cancer in radical prostatectomy specimens
4. Diagnostic criteria of limited adenocarcinoma of the prostate on needle biopsy
5. The pathological interpretation and significance of prostate needle biopsy findings: Implications and current controversies
6. Pathological and clinical findings to predict tumor extent of non-palpable (stage Tlc) prostate cancer
7. Benign mimics of prostatic adenocarcinoma on needle biopsy
8. Monoclonal antibodies to human intermediate filament proteins: Distribution of filament proteins in normal human tissues
9. Use of keratin 903 as an adjunct in the diagnosis of prostate carcinoma
10. Relationship between serum prostate specific antigen, needle biopsy findings, and histopathologic features of prostatic carcinoma in radical prostatectomy tissues
11. P504S: A new molecular marker for the detection of prostate carcinoma
12. Cancer statistics, 1999
13. α-methylacyl-coa racemase: A new molecular marker for prostate cancer
14. α-methylacyl co-enzyme A racemase as a tissue biomaker for prostate cancer
15. Diagnostic errors in surgical pathology uncovered by a review of malpractice claims: Part 1. General considerations
16. The utility of basal cell-specific anticytokeratin antibody (34βE12) in the diagnosis of prostate cancer
17. Identification of differentially expressed genes in human prostate cancer using subtraction and microarray
18. Expression of α-methylacyl Co A racemase (P504S) in atypical adenomatous hyperplasia of the prostate